학술논문
Retrospective Case Series of Aripiprazole Augmentation in Pervasive Developmental Disorders
이용수 0
- 영문명
- 발행기관
- 대한신경정신의학회
- 저자명
- Yeni Kim SooChurl Cho MinSup Shin JaeWon Kim SeungHee Lee BoongNyun Kim
- 간행물 정보
- 『Psychiatry Investigation』제7권 제3호, 220~223쪽, 전체 4쪽
- 주제분류
- 의약학 > 정신과학
- 파일형태
- 발행일자
- 2010.09.30
4,000원
구매일시로부터 72시간 이내에 다운로드 가능합니다.
이 학술논문 정보는 (주)교보문고와 각 발행기관 사이에 저작물 이용 계약이 체결된 것으로, 교보문고를 통해 제공되고 있습니다.
국문 초록
영문 초록
Due to co-morbidities and treatment resistant nature of pervasive developmental disorder (PDD), diverse combinations of regimens have been tried. This retrospective study aimed to explore adjunctive use of aripiprazole in children with PDD. Changes in illness severity were measured by Clinical Global Impression of Severity (CGI-S) and Clinical Global Impression of Improvement (CGI-I) in 14 aripiprazole-treated patients with PDD. Improvement of illness severity was observed after aripiprazole add-on (5.8±0.8 to 4.9±1.0, Z=-2.75, p=0.001). Mean dosage was 7.7 mg/day [standard deviation (SD) 3.3, range 5-15]. A higher mean dosage was observed in group with improvement in symptoms (t=-2.33, df =12, p=0.004). The target symptoms most effectively improved after using aripiprazole were positive psychotic symptoms (mean CGI-I: 2.0±1.4, 3 responders/4 patients, 75% response) followed by aggressive behavior (2.5±1.7, 3/4, 75%), self-injurious behavior (2.0±1.0, 2/3, 67%), stereotypic behavior (2.7±1.2, 2/3, 67%), tic (2.8±1.0, 2/4, 50%), irritability (3.5±2.1, 1/2, 50%), obsessive behavior (2.5±2.1, 1/3, 33%), hyperactivity (3.4±1.6, 3/7, 43%) and mood fluctuation (3, 0/1, no response). Five patients (35%) discontinued aripiprazole due to treatment-emergent adverse effects (akathisia, insomnia, withdrawal). The results of this study suggest that aripiprazole augmentation may be used safely in maladaptive behaviors of some populations of PDD. However, future studies are required to con-firm these preliminary findings.
목차
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES
해당간행물 수록 논문
- Association between Estrogen Receptor Gene Polymorphisms and Depression in Post-Menopausal Women: A Preliminary Study
- Cholestatic Jaundice Induced by Duloxetine in a Patient with Major Depressive Disorder
- Changes in Cerebral Cortex and Limbic Brain Functions after Short-Term Paroxetine Treatment in Panic Disorder: An [18F]FDG-PET Pilot Study
- Current Use of Depression Rating Scales in Mental Health Setting
- Retrospective Case Series of Aripiprazole Augmentation in Pervasive Developmental Disorders
- Increased Glycogen Synthase Kinase-3β mRNA Level in the Hippocampus of Patients with Major Depression: A Study Using the Stanley Neuropathology Consortium Integrative Database
- Genetic Association Study of the Alpha 7 Nicotinic Receptor (CHRNA7) with the Development of Schizophrenia and Bipolar Disorder in Korean Population
- The Positive and Negative Affect Schedule: Psychometric Properties of the Korean Version
- Efficacy and Tolerability of Aripiprazole: A 26-Week Switching Study from Oral Antipsychotics
- Frontal Dysfunction Underlies Depression in Mild Cognitive Impairment: A FDG-PET Study
- Impairment of Concept Formation Ability in Children with ADHD: Comparisons between Lower Grades and Higher Grades
- Psychopharmacological Treatment Status in Outpatients with Bipolar Disorder: A Clinical Survey in Germany
참고문헌
교보eBook 첫 방문을 환영 합니다!
신규가입 혜택 지급이 완료 되었습니다.
바로 사용 가능한 교보e캐시 1,000원 (유효기간 7일)
지금 바로 교보eBook의 다양한 콘텐츠를 이용해 보세요!